Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS).
about
Treatment for lupus nephritisMycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritisPaediatric use of mycophenolate mofetil.Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trialWhy can't we find a new treatment for SLE?Mycophenolate mofetil in the treatment of lupus nephritis.Beyond immunosuppression - challenges in the clinical management of lupus nephritis.Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS studyTreatment of systemic lupus erythematosus: new advances in targeted therapy.Diagnosis and treatment of lupus nephritis flares--an update.Mycophenolate mofetil in the treatment of systemic lupus erythematosus.Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome.Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.A decade of mycophenolate mofetil for lupus nephritis: is the glass half-empty or half-full?Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.Mycophenolate mofetil has potent anti-inflammatory actions in a mouse model of acute lung injury.Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus.Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis.Lupus nephritis is more severe in children and adolescents than in older adults.Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trialThe effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis
P2860
Q24202572-BAAD3B75-A03C-4A53-BB0D-D7022C419F23Q34462600-E427BB99-B46B-4BAE-BF8E-28E084AA00EEQ34975939-594C8CF8-C46A-4A05-B04C-754E86BA942EQ36562448-024BE498-D6C4-413A-8E5E-CBAD9DFA4607Q36802054-63263977-BCF6-46FB-9BAD-B1202B609E34Q37086991-A54F6B7A-926C-4988-B258-41912E3E43EDQ37236049-7B5E3919-5D4F-43A9-A41E-D70FE5E277E1Q37290624-0D1865BA-85B8-4AE9-8EFC-C6C5FF3552E3Q37371383-BD70204F-C822-446C-AFD8-78589DF100BDQ37462538-2ECEC466-D31F-42A7-96AB-84E72A6FF219Q37974990-8D9FA14B-C00C-48EA-B77B-08F03B8F6C75Q38059445-93D23830-B480-4EAA-8AA7-B6C98BF0D0FFQ38327763-1B35EE84-587D-4D65-9364-12CF220AEA04Q39218839-318D768D-BC3F-4D7A-A75D-3882CF6E9658Q40891083-8E72EC62-80E0-434B-8660-72245432C5C3Q41114245-EE13940A-E067-4BDD-9BB7-DADF702FC926Q42511206-D9989C24-FBD6-4F3F-BE24-7F2169C4938CQ43101009-4ADB0825-703B-41D2-A713-FB3239F1498BQ46049455-D2FDD74C-13DC-47BE-AF52-E787F241D111Q46374758-D6895D53-5926-43D5-AAE3-4C85E91895BEQ46769274-251AD278-58A1-4059-904A-447BE468487AQ51140299-8B0A927F-D9FB-4F31-9318-E39F9EAF9924Q51350730-217845F8-6D65-4A3D-95B3-67438F925E8EQ57213088-0EC383A0-7A49-4229-A5B9-D0EE9070846CQ57226203-E534C06E-7D4B-427A-8874-29AB7806D385
P2860
Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS).
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mycophenolate mofetil as induc ...... Lupus Management Study (ALMS).
@en
Mycophenolate mofetil as induc ...... Lupus Management Study (ALMS).
@nl
type
label
Mycophenolate mofetil as induc ...... Lupus Management Study (ALMS).
@en
Mycophenolate mofetil as induc ...... Lupus Management Study (ALMS).
@nl
prefLabel
Mycophenolate mofetil as induc ...... Lupus Management Study (ALMS).
@en
Mycophenolate mofetil as induc ...... Lupus Management Study (ALMS).
@nl
P2093
P2860
P356
P1433
P1476
Mycophenolate mofetil as induc ...... Lupus Management Study (ALMS).
@en
P2093
A Sinclair
M A Dooley
N Solomons
P2860
P304
P356
10.1177/0961203307084712
P577
2007-01-01T00:00:00Z